![](/img/cover-not-exists.png)
Exenatide elicits sustained glycaemic control and progressive reduction of body weight in patients with type 2 diabetes inadequately controlled by sulphonylureas with or without metformin
Matthew C. Riddle, Robert R. Henry, Terri H. Poon, Bei Zhang, Susanna M. Mac, John H. Holcombe, Dennis D. Kim, David G. MaggsVolume:
22
Year:
2006
Language:
english
Pages:
9
DOI:
10.1002/dmrr.646
File:
PDF, 161 KB
english, 2006